Company / Current Assets per Share
Cardiff Oncology, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.90
FY2025
5-year range
$0.90 / $3.97
FY2021-FY2025
Trend
-57.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 10 years, ranging from $0.31 in FY2017 to $17.41 in FY2018.
Based on SEC 10-K filings.
0.90 in FY2025 with a 5-year CAGR of -43.4%.
Declined from $1.73 to $0.90 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -30.1%
- 5-Year CAGR
- -43.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share decreased 57.5% year-over-year.
- Peak current assets per share was recorded in FY2018.
- Lowest current assets per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.90 | -57.5% |
| FY2024 | $2.13 | +22.8% |
| FY2023 | $1.73 | -34.7% |
| FY2022 | $2.65 | -33.3% |
| FY2021 | $3.97 | -74.4% |
| FY2020 | $15.52 | +423.7% |
| FY2019 | $2.96 | -83.0% |
| FY2018 | $17.41 | +5544.2% |
| FY2017 | $0.31 | -76.4% |
| FY2016 | $1.31 | -63.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026